Loading
Loading
Thymosin Beta-4 fragment · actin-binding peptide
A synthetic fragment of Thymosin Beta-4, the primary actin-sequestering peptide in mammalian cells. Investigated for its role in tissue remodeling and cell-migration research.
TB-500 is a synthetic fragment of Thymosin Beta-4, the primary actin-sequestering peptide in mammalian cells, studied for cell-migration and tissue-remodeling research.
TB-500 (Thymosin Beta-4 fragment, residues 17–23) acts as a major regulator of cellular actin. Preclinical studies have examined its effects on cell migration, angiogenesis, and tissue repair following injury.
CoA available on request
Every TB-500 lot is independently tested in Dubai or the UK and ships with its signed Certificate of Analysis in the box. To review the CoA for a specific lot before ordering, email support@caesarbiomedical.com with the lot number, or look it up on our verification page.
For laboratory research use only.
Join the research letter for monthly briefings on peptide science, lab data updates, and the kind of writing your inbox actually deserves.
The research letter
One email per month. Citations included. Zero filler.